Dispatched same day before 4pm

FOXO4-DRI research vial

FOXO4-DRI

Senolytic Peptide. Supplied in 5 and 10 mg vials, lyophilised and ready to reconstitute.

Batch certified
UK stock, same-day
Stored cold, shipped & sealed safely
Strength
How many vials?

2 more vials to save 5%

£55.00 from free UK delivery
Total£45.00

Ships today

Questions about FOXO4-DRI? Ask us

For laboratory research use only. Not for human or veterinary use, and not a medicine, food, or cosmetic. Sold to qualified researchers and institutions.

About FOXO4-DRI

Residues
34

FOXO4-DRI is a D-retro-inverso peptide (all D-amino acids in reversed order) designed from the FOXO4 region that interacts with the p53 transactivation domain, engineered to resist proteolysis while preserving binding geometry. In research it is studied as a senolytic tool that perturbs the FOXO4-p53 interaction, promoting p53 nuclear exclusion and apoptosis selectively in senescent cells.

For laboratory research use only. Not for human or veterinary use.

Specifications

HydrophobicPolarAcidicBasic
34 residues
Identity
Sequence
LTLRKEPASEIAQSILEAYSQNGWANRRSGGKRP
Molecular formula
not recorded
Molecular weight
not recorded
CAS number
not recorded
Physical
Form
Lyophilised powder
Appearance
White to off-white powder
Solubility
Soluble in bacteriostatic or sterile water
Storage
Store the lyophilised powder at -20°C, protected from light. Refrigerate reconstituted material at 2 to 8°C and use within its stability window.
This batch
Purity
98.9%
Lot
PX-2427-B
Test date
May 2026
Testing lab
third-party
Methods
HPLC, LC-MS/MS

Certificate

Certificate · lot PX-2427-B98.9% · HPLC / LC-MS/MS · May 2026

Handling and storage

Reconstitute with bacteriostatic or sterile water. Store the lyophilised powder at -20°C, protected from light; refrigerate reconstituted material at 2 to 8°C. Handle under standard laboratory conditions.

Literature

Published third-party research on this compound, listed for reference. These are the findings of the cited authors, not claims about the material we supply.

Common questions about FOXO4-DRI

What is FOXO4-DRI?
FOXO4-DRI is a D-retro-inverso peptide (all D-amino acids in reversed order) designed from the FOXO4 region that interacts with the p53 transactivation domain, engineered to resist proteolysis while preserving binding geometry.
How is FOXO4-DRI supplied?
FOXO4-DRI is supplied as a lyophilised (freeze-dried) powder in 5 mg and 10 mg vials, for laboratory research use only.
How should FOXO4-DRI be stored and handled?
Reconstitute with bacteriostatic or sterile water. Store the lyophilised powder at -20°C, protected from light; refrigerate reconstituted material at 2 to 8°C. Handle under standard laboratory conditions.
Has this batch of FOXO4-DRI been independently tested?
Yes. Lot PX-2427-B was tested at 98.9% by an independent laboratory. The full certificate of analysis is published and searchable by lot code on the verify page, before and after purchase.
Is FOXO4-DRI for human use?
No. FOXO4-DRI is supplied strictly for in vitro laboratory research. It is not for human or veterinary use, and is not a medicine, food, or cosmetic.

Researchers also study

5-Amino-1MQ research vial
New50 mg

5-Amino-1MQ

£60.00£1.20/mg
Dispatches today
AOD-9604 research vial
2 / 5 mg

AOD-9604

from £18.00£6.00/mg
Dispatches today
PT-141 research vial
10 mg

PT-141

£28.00£2.80/mg
Dispatches today
PNC-27 research vial
5 mg

PNC-27

£40.00£8.00/mg
Out of stock

Reconstitution

Concentration
2.50 mg/ml
Volume to draw
0.100 ml
On a U-100 syringe
10 units

A measurement aid for laboratory handling. For research use only.

Need the syringe mark, a round-number draw, or a U-40 reading? Open the full calculator with this 5 mg vial loaded.